< Back to previous page

Publication

High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib

Book Contribution - Book Abstract Conference Contribution

Book: JOURNAL OF CLINICAL ONCOLOGY
Volume: 36
Number of pages: 1